Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Interagency collaboration models for people with mental ill health in contact with the police: a systematic scoping review.

Parker A, Scantlebury A, Booth A, MacBryde JC, Scott WJ, Wright K, McDaid C.

BMJ Open. 2018 Mar 27;8(3):e019312. doi: 10.1136/bmjopen-2017-019312.

2.

Undertaking a randomised controlled trial in the police setting: methodological and practical challenges.

Scantlebury A, McDaid C, Booth A, Fairhurst C, Parker A, Payne R, Reed H, Scott WJ, Torgerson D, Hewitt C.

Trials. 2017 Dec 22;18(1):615. doi: 10.1186/s13063-017-2369-6.

3.

Lung Resection in the Postpneumonectomy Patient.

Asai M, Scott WJ.

Thorac Surg Clin. 2018 Feb;28(1):19-25. doi: 10.1016/j.thorsurg.2017.08.004. Review.

PMID:
29150034
4.

Effectiveness of a training program for police officers who come into contact with people with mental health problems: A pragmatic randomised controlled trial.

Scantlebury A, Fairhurst C, Booth A, McDaid C, Moran N, Parker A, Payne R, Scott WJ, Torgerson D, Webber M, Hewitt C.

PLoS One. 2017 Sep 8;12(9):e0184377. doi: 10.1371/journal.pone.0184377. eCollection 2017.

5.

Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer.

Dalton BGA, Friedant AJ, Su S, Schatz TAP, Ruth KJ, Scott WJ.

J Laparoendosc Adv Surg Tech A. 2017 Dec;27(12):1279-1283. doi: 10.1089/lap.2017.0320. Epub 2017 Aug 4.

PMID:
28777676
6.

Iraq and Afghanistan Veterans' Use of Veterans Health Administration and Purchased Care Before and After Veterans Choice Program Implementation.

Vanneman ME, Harris AHS, Asch SM, Scott WJ, Murrell SS, Wagner TH.

Med Care. 2017 Jul;55 Suppl 7 Suppl 1:S37-S44. doi: 10.1097/MLR.0000000000000678.

PMID:
28146036
7.

Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.

Rice TW, Ishwaran H, Hofstetter WL, Schipper PH, Kesler KA, Law S, Lerut EM, Denlinger CE, Salo JA, Scott WJ, Watson TJ, Allen MS, Chen LQ, Rusch VW, Cerfolio RJ, Luketich JD, Duranceau A, Darling GE, Pera M, Apperson-Hansen C, Blackstone EH.

Ann Surg. 2017 Jan;265(1):122-129. doi: 10.1097/SLA.0000000000001594.

8.

BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models.

Politz O, Siegel F, Bärfacker L, Bömer U, Hägebarth A, Scott WJ, Michels M, Ince S, Neuhaus R, Meyer K, Fernández-Montalván AE, Liu N, von Nussbaum F, Mumberg D, Ziegelbauer K.

Int J Cancer. 2017 Jan 15;140(2):449-459. doi: 10.1002/ijc.30457. Epub 2016 Oct 20.

9.

Worldwide Esophageal Cancer Collaboration: clinical staging data.

Rice TW, Apperson-Hansen C, DiPaola LM, Semple ME, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KN, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Blackstone EH.

Dis Esophagus. 2016 Oct;29(7):707-714. doi: 10.1111/dote.12493.

10.

Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data.

Rice TW, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, van Lanschot J, Chen KN, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Apperson-Hansen C, DiPaola LM, Semple ME, Blackstone EH.

Dis Esophagus. 2016 Oct;29(7):715-723. doi: 10.1111/dote.12513.

11.

Worldwide Esophageal Cancer Collaboration: pathologic staging data.

Rice TW, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KL, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Cecconello I, Allum WH, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Lerut TE, Orringer MB, Ishwaran H, Apperson-Hansen C, DiPaola LM, Semple ME, Blackstone EH.

Dis Esophagus. 2016 Oct;29(7):724-733. doi: 10.1111/dote.12520.

12.

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H.

J Natl Compr Canc Netw. 2016 Oct;14(10):1286-1312.

PMID:
27697982
13.

Comparison of vitreous loss rates between manual phacoemulsification and femtosecond laser-assisted cataract surgery.

Scott WJ, Tauber S, Gessler JA, Ohly JG, Owsiak RR, Eck CD.

J Cataract Refract Surg. 2016 Jul;42(7):1003-8. doi: 10.1016/j.jcrs.2016.04.027.

PMID:
27492098
14.

Discovery and SAR of Novel 2,3-Dihydroimidazo[1,2-c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80-6946).

Scott WJ, Hentemann MF, Rowley RB, Bull CO, Jenkins S, Bullion AM, Johnson J, Redman A, Robbins AH, Esler W, Fracasso RP, Garrison T, Hamilton M, Michels M, Wood JE, Wilkie DP, Xiao H, Levy J, Stasik E, Liu N, Schaefer M, Brands M, Lefranc J.

ChemMedChem. 2016 Jul 19;11(14):1517-30. doi: 10.1002/cmdc.201600148. Epub 2016 Jun 16.

15.

Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer.

Shaikh T, Churilla TM, Monpara P, Scott WJ, Cohen SJ, Meyer JE.

Pract Radiat Oncol. 2016 Nov - Dec;6(6):388-394. doi: 10.1016/j.prro.2016.02.004. Epub 2016 Feb 27.

16.

Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection.

Boland PM, Meyer JE, Berger AC, Cohen SJ, Neuman T, Cooper HS, Olszanski AJ, Davey M, Cheng JD, Lebenthal A, Burtness BA, Scott WJ, Astsaturov IA.

Am J Clin Oncol. 2017 Aug;40(4):393-398. doi: 10.1097/COC.0000000000000171.

PMID:
26986978
17.

Minimally Invasive versus Open Thymectomy for Thymic Malignancies: Systematic Review and Meta-Analysis.

Friedant AJ, Handorf EA, Su S, Scott WJ.

J Thorac Oncol. 2016 Jan;11(1):30-8. doi: 10.1016/j.jtho.2015.08.004. Review.

18.

Potential confounding factors in a comparison of femtosecond laser-assisted cataract surgery versus standard phacoemulsification.

Talamo JH, Dick HB, Schultz T, Scott WJ.

J Cataract Refract Surg. 2015 Aug;41(8):1792. doi: 10.1016/j.jcrs.2015.06.026. No abstract available.

PMID:
26432150
19.

Femtosecond laser-assisted primary posterior capsulotomy for toric intraocular lens fixation and stabilization.

Scott WJ, Owsiak RR.

J Cataract Refract Surg. 2015 Aug;41(8):1767-71. doi: 10.1016/j.jcrs.2015.07.002.

PMID:
26432136
20.

Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion.

Hall MJ, Innocent J, Rybak C, Veloski C, Scott WJ, Wu H, Ridge JA, Hoffman JP, Borghaei H, Turaka A, Daly MB.

Appl Clin Genet. 2015 Feb 17;8:69-73. doi: 10.2147/TACG.S72223. eCollection 2015.

21.

Esophageal and esophagogastric junction cancers, version 1.2015.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Feb;13(2):194-227.

PMID:
25691612
22.

Emergency eye rinse for chemical injuries: new considerations.

Scott WJ, Schrage N, Dohlman C.

JAMA Ophthalmol. 2015 Mar;133(3):245. doi: 10.1001/jamaophthalmol.2014.5045. No abstract available.

PMID:
25474079
23.

Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.

Shaikh T, Ruth K, Scott WJ, Burtness BA, Cohen SJ, Konski AA, Cooper HS, Astsaturov I, Meyer JE.

Ann Thorac Surg. 2015 Jan;99(1):270-6. doi: 10.1016/j.athoracsur.2014.08.033. Epub 2014 Nov 18.

24.

Lost opportunities: coral recruitment does not translate to reef recovery in the Florida Keys.

van Woesik R, Scott WJ 4th, Aronson RB.

Mar Pollut Bull. 2014 Nov 15;88(1-2):110-7. doi: 10.1016/j.marpolbul.2014.09.017. Epub 2014 Sep 27.

PMID:
25266950
25.

Re: Abell et al.: anterior capsulotomy integrity after femtosecond laser-assisted cataract surgery (ophthalmology 2014;121:17-24).

Scott WJ.

Ophthalmology. 2014 Jul;121(7):e35-6. doi: 10.1016/j.ophtha.2014.02.014. Epub 2014 Mar 25. No abstract available.

PMID:
24679836
26.

Flawed culture method in povidone-iodine cataract surgery prep study.

Scott WJ.

J Cataract Refract Surg. 2014 Jan;40(1):169-70. doi: 10.1016/j.jcrs.2013.11.008. No abstract available.

PMID:
24355742
27.

Reply: To PMID 23608565.

Dick HB, Schultz T, Scott WJ.

J Cataract Refract Surg. 2014 Jan;40(1):168-9. doi: 10.1016/j.jcrs.2013.11.012. No abstract available.

PMID:
24355741
28.

Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial.

Su S, Scott WJ, Allen MS, Darling GE, Decker PA, McKenna RJ, Meyers BF.

J Thorac Cardiovasc Surg. 2014 Feb;147(2):747-52: Discussion 752-3. doi: 10.1016/j.jtcvs.2013.10.001. Epub 2013 Nov 26. Erratum in: J Thorac Cardiovasc Surg. 2014 Aug;148(2):756.

29.

BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models.

Liu N, Rowley BR, Bull CO, Schneider C, Haegebarth A, Schatz CA, Fracasso PR, Wilkie DP, Hentemann M, Wilhelm SM, Scott WJ, Mumberg D, Ziegelbauer K.

Mol Cancer Ther. 2013 Nov;12(11):2319-30. doi: 10.1158/1535-7163.MCT-12-0993-T. Epub 2013 Oct 29.

30.

Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.

Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 May 1;11(5):531-46.

PMID:
23667204
31.

Initial results of minimally invasive Ivor Lewis esophagectomy after induction chemoradiation (50.4 gy) for esophageal cancer.

Thomay AA, Snyder JA, Edmondson DM, Scott WJ.

Innovations (Phila). 2012 Nov-Dec;7(6):421-8. doi: 10.1097/IMI.0b013e31828130b7.

PMID:
23422805
32.

Disparities in access to video-assisted thoracic surgical lobectomy for treatment of early-stage lung cancer.

Stitzenberg KB, Shah PC, Snyder JA, Scott WJ.

J Laparoendosc Adv Surg Tech A. 2012 Oct;22(8):753-7. doi: 10.1089/lap.2012.0095. Epub 2012 Jun 27.

PMID:
22738616
33.

Benign metastasizing leiomyoma: a rare cause of multiple pulmonary nodules.

Rege AS, Snyder JA, Scott WJ.

Ann Thorac Surg. 2012 Jun;93(6):e149-51. doi: 10.1016/j.athoracsur.2011.12.047.

PMID:
22632533
34.

Povidone-iodine and ophthalmia neonatorum.

Scott WJ, Eck CD.

Ophthalmology. 2012 Mar;119(3):653-4; author reply 654. doi: 10.1016/j.ophtha.2011.11.037. No abstract available.

PMID:
22385492
35.

Invited commentary.

Scott WJ.

Ann Thorac Surg. 2012 Jan;93(1):265. doi: 10.1016/j.athoracsur.2011.09.009. No abstract available.

PMID:
22186444
36.

Esophageal and esophagogastric junction cancers.

Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK Jr, Warren G, Washington MK, Willett C, Wright CD; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Aug 1;9(8):830-87. No abstract available.

PMID:
21900218
37.

Povidone-iodine antisepsis for cataract surgery and ophthalmic procedures.

Scott WJ.

Am J Ophthalmol. 2011 May;151(5):914; author reply 914-5. doi: 10.1016/j.ajo.2011.01.039. No abstract available.

PMID:
21501706
38.

An updated history of the Teratology Society.

Shepard TH, Barr M Jr, Brent RL, Hendrickx A, Kochhar D, Oakley G, Scott WJ Jr, Rogers JM.

Birth Defects Res A Clin Mol Teratol. 2010 May;88(5):263-85. doi: 10.1002/bdra.20669. Review.

39.

Gastric cancer.

Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G; NCCN Gastric Cancer Panel.

J Natl Compr Canc Netw. 2010 Apr;8(4):378-409. No abstract available.

PMID:
20410333
40.
41.

Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial.

Scott WJ, Allen MS, Darling G, Meyers B, Decker PA, Putnam JB, McKenna RW, Landrenau RJ, Jones DR, Inculet RI, Malthaner RA.

J Thorac Cardiovasc Surg. 2010 Apr;139(4):976-81; discussion 981-3. doi: 10.1016/j.jtcvs.2009.11.059. Epub 2010 Feb 20.

42.

Optimum lymphadenectomy for esophageal cancer.

Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Hofstetter WL, Watson TJ, Allen MS, Rusch VW, Blackstone EH.

Ann Surg. 2010 Jan;251(1):46-50. doi: 10.1097/SLA.0b013e3181b2f6ee.

PMID:
20032718
43.

Microarray analysis of murine limb bud ectoderm and mesoderm after exposure to cadmium or acetazolamide.

Schreiner CM, Bell SM, Scott WJ Jr.

Birth Defects Res A Clin Mol Teratol. 2009 Jul;85(7):588-98. doi: 10.1002/bdra.20577.

PMID:
19274763
44.

Worldwide esophageal cancer collaboration.

Rice TW, Rusch VW, Apperson-Hansen C, Allen MS, Chen LQ, Hunter JG, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Swisher SG, Watson TJ, Blackstone EH.

Dis Esophagus. 2009;22(1):1-8. doi: 10.1111/j.1442-2050.2008.00901.x.

PMID:
19196264
45.

Esophageal cancer.

Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Ilson DH, Kleinberg LR, McAleer MF, Meropol NJ, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Swisher SG, Washington MK, Willett C, Wood DE, Wright CD, Yang G; NCCN Esophageal Cancer Panel.

J Natl Compr Canc Netw. 2008 Oct;6(9):818-49. No abstract available.

PMID:
18926093
46.

Surgical treatment of metastatic disease to the lung.

Quiros RM, Scott WJ.

Semin Oncol. 2008 Apr;35(2):134-46. doi: 10.1053/j.seminoncol.2007.12.010. Review.

PMID:
18396199
47.

R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis.

Bell SM, Schreiner CM, Wert SE, Mucenski ML, Scott WJ, Whitsett JA.

Development. 2008 Mar;135(6):1049-58. doi: 10.1242/dev.013359. Epub 2008 Feb 6.

48.

Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).

Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K; American College of Chest Physicians.

Chest. 2007 Sep;132(3 Suppl):234S-242S.

PMID:
17873171
49.

SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer.

Wickens P, Kluender H, Dixon J, Brennan C, Achebe F, Bacchiocchi A, Bankston D, Bierer D, Brands M, Braun D, Brown MS, Chuang CY, Dumas J, Enyedy I, Hofilena G, Hong Z, Housley T, Jones B, Khire U, Kreiman C, Kumarasinghe E, Lowinger T, Ott-Morgan R, Perkins L, Phillips B, Schoenleber R, Scott WJ, Sheeler R, Redman A, Sun X, Taylor I, Wang L, Wilhelm S, Zhang X, Zhang M, Sullivan E, Carter C, Miglarese M, Levy J.

Bioorg Med Chem Lett. 2007 Aug 1;17(15):4378-81. Epub 2007 Mar 3.

PMID:
17574417
50.

4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidate.

Wood J, Bagi CM, Akuche C, Bacchiocchi A, Baryza J, Blue ML, Brennan C, Campbell AM, Choi S, Cook JH, Conrad P, Dixon BR, Ehrlich PP, Gane T, Gunn D, Joe T, Johnson JS, Jordan J, Kramss R, Liu P, Levy J, Lowe DB, McAlexander I, Natero R, Redman AM, Scott WJ, Town C, Wang M, Wang Y, Zhang Z.

Bioorg Med Chem Lett. 2006 Sep 15;16(18):4965-8. Epub 2006 Jun 27.

PMID:
16806919

Supplemental Content

Loading ...
Support Center